Clinical update: irritable bowel syndrome. 2007

Robin Spiller
Wolfson Digestive Diseases Centre, University Hospital, Nottingham NG7 2UH, UK. Robin.Spiller@nottingham.ac.uk

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010276 Parasympatholytics Agents that inhibit the actions of the parasympathetic nervous system. The major group of drugs used therapeutically for this purpose is the MUSCARINIC ANTAGONISTS. Antispasmodic,Antispasmodic Agent,Antispasmodic Drug,Antispasmodics,Parasympathetic-Blocking Agent,Parasympathetic-Blocking Agents,Parasympatholytic,Parasympatholytic Agent,Parasympatholytic Drug,Spasmolytic,Spasmolytics,Antispasmodic Agents,Antispasmodic Drugs,Antispasmodic Effect,Antispasmodic Effects,Parasympatholytic Agents,Parasympatholytic Drugs,Parasympatholytic Effect,Parasympatholytic Effects,Agent, Antispasmodic,Agent, Parasympathetic-Blocking,Agent, Parasympatholytic,Agents, Antispasmodic,Agents, Parasympathetic-Blocking,Agents, Parasympatholytic,Drug, Antispasmodic,Drug, Parasympatholytic,Drugs, Antispasmodic,Drugs, Parasympatholytic,Effect, Antispasmodic,Effect, Parasympatholytic,Effects, Antispasmodic,Effects, Parasympatholytic,Parasympathetic Blocking Agent,Parasympathetic Blocking Agents
D003937 Diagnosis, Differential Determination of which one of two or more diseases or conditions a patient is suffering from by systematically comparing and contrasting results of diagnostic measures. Diagnoses, Differential,Differential Diagnoses,Differential Diagnosis
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D016032 Randomized Controlled Trials as Topic Works about clinical trials that involve at least one test treatment and one control treatment, concurrent enrollment and follow-up of the test- and control-treated groups, and in which the treatments to be administered are selected by a random process, such as the use of a random-numbers table. Clinical Trials, Randomized,Controlled Clinical Trials, Randomized,Trials, Randomized Clinical
D043183 Irritable Bowel Syndrome A disorder with chronic or recurrent colonic symptoms without a clearcut etiology. This condition is characterized by chronic or recurrent ABDOMINAL PAIN, bloating, MUCUS in FECES, and an erratic disturbance of DEFECATION. Colitis, Mucous,Colon, Irritable,Colitides, Mucous,Irritable Bowel Syndromes,Irritable Colon,Mucous Colitides,Mucous Colitis,Syndrome, Irritable Bowel,Syndromes, Irritable Bowel

Related Publications

Robin Spiller
May 1979, Missouri medicine,
Robin Spiller
December 2003, Postgraduate medical journal,
Robin Spiller
January 1985, American family physician,
Robin Spiller
December 2020, Gastroenterology & hepatology,
Robin Spiller
April 2019, Current gastroenterology reports,
Robin Spiller
March 2012, Clinics in colon and rectal surgery,
Robin Spiller
April 2008, The New England journal of medicine,
Robin Spiller
August 2012, The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology,
Robin Spiller
July 2001, Expert opinion on investigational drugs,
Robin Spiller
October 2000, Advance for nurse practitioners,
Copied contents to your clipboard!